{Reference Type}: Journal Article
{Title}: A crisis in clinical research.
{Author}: Hong DS;LoRusso P;Sznol M;
{Journal}: J Immunother Cancer
{Volume}: 12
{Issue}: 7
{Year}: 2024 Jul 11
{Factor}: 12.469
{DOI}: 10.1136/jitc-2023-008520
{Abstract}: The clinical research pipeline is critical to ensuring continued development of novel treatments that can offer patients with cancer safe and effective options. Unfortunately, progress has slowed since the COVID-19 pandemic due to uncovered, systemic inefficiencies across critical processes. Towards initiating discussion on how to reinvigorate clinical research, the Society for Immunotherapy of Cancer (SITC) hosted a virtual summit that characterized issues and formed potential solutions. This commentary serves to highlight the crisis facing clinical research as well as stimulate field-wide discussion on how to better serve patients into the future.